Oleg B. Talibov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oleg B. Talibov has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Eduard Bezuglov
Department of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Moscow, Russia
13 shared publications - Artemii Lazarev
Mount Sinai Hospital
6 shared publications - Ryland Morgans
Department of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Moscow, Russia
6 shared publications - Georgiy Malyakin
Department of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Moscow, Russia
5 shared publications - Zbigniew Waśkiewicz
Institute of Sport Science, Jerzy Kukuczka Academy of Physical Education in Katowice, 40-065 Katowice, Poland
5 shared publications - Elizaveta Kapralova
Department of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University of the Ministry of Health of the Russia Federation, Moscow, Russia
4 shared publications
Latest Publications
- 7 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7)
Results of the meeting of the Interdisciplinary Expert Council on an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders
The reduction in sex hormone levels during the menopausal period substantially impacts patients’ quality of life and serves as a significant risk factor for psycho-emotional disorders. Current clinical guidelines from both Russian and international sources recognize menopausal hormone therapy (MHT) as the primary method for addressing menopausal disorders. However, selecting dosage forms tailored to the patient’s comorbidities and overall health status is essential. In 2026, the Russian Association of Obstetricians and Gynecologists, the Interdisciplinary Association of Specialists in Healthy Aging and Anti-Aging Medicine, and the Russian Society for the Study of Headache established an interdisciplinary council to implement an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders. The objectives of the expert council included discussing contemporary management strategies for peri- and postmenopausal women and optimizing the application of MHT in complex clinical cases. Additionally, the council aimed to enhance scientific methodologies and devise algorithms for managing patients presenting with menopausal symptoms due to estrogen deficiency, alongside neurological and psycho-emotional disorders. The collaborative efforts of the experts culminated in a consensus document that outlines key principles for the administration of MHT to women with psycho-emotional disorders and somatic comorbidities during the peri- and postmenopausal stages.
- 7 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7)
Results of the meeting of the Interdisciplinary Expert Council on an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders
The reduction in sex hormone levels during the menopausal period substantially impacts patients’ quality of life and serves as a significant risk factor for psycho-emotional disorders. Current clinical guidelines from both Russian and international sources recognize menopausal hormone therapy (MHT) as the primary method for addressing menopausal disorders. However, selecting dosage forms tailored to the patient’s comorbidities and overall health status is essential. In 2026, the Russian Association of Obstetricians and Gynecologists, the Interdisciplinary Association of Specialists in Healthy Aging and Anti-Aging Medicine, and the Russian Society for the Study of Headache established an interdisciplinary council to implement an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders. The objectives of the expert council included discussing contemporary management strategies for peri- and postmenopausal women and optimizing the application of MHT in complex clinical cases. Additionally, the council aimed to enhance scientific methodologies and devise algorithms for managing patients presenting with menopausal symptoms due to estrogen deficiency, alongside neurological and psycho-emotional disorders. The collaborative efforts of the experts culminated in a consensus document that outlines key principles for the administration of MHT to women with psycho-emotional disorders and somatic comorbidities during the peri- and postmenopausal stages.
- Open Access
- 3 August 2026
- Published by Endocrinology Research Centre in Bulletin of Reproductive Health
- Vol. 5 (2) , 10-26
Consensus statement on the results of the interdisciplinary expert council meeting with international participation on personalized prescription of hormone replacement therapy/menopausal hormone therapy in women at different age period
A significant decrease in estrogen levels due to the onset of menopause is the cause of the development of clinically significant symptoms of climacteric syndrome, which significantly impair the quality of life, and also refers to factors that increase long-term cardiometabolic risks. According to the current Russian clinical recommendations, menopausal hormone therapy (MHT) is considered as the most effective method for the correction of climacteric disorders. An Interdisciplinary Expert Council was convened in the last quarter of 2025 to study the topical issues of managing patients in the peri-and postmenopausal periods and the specifics of prescribing MHT in various clinical situations, the main task of which was to optimize scientifically based algorithms for the management of patients with climacteric/postovariectomy syndromes. Based on the results of work by national and international specialists representing various fields of medicine, a consensus document was approved regulating the principles for prescribing HRT/MHT to women with concomitant somatic pathology.
- 3 August 2026
- Published by Endocrinology Research Centre in Bulletin of Reproductive Health
- Vol. 5 (2) , 10-26
Open AccessConsensus statement on the results of the interdisciplinary expert council meeting with international participation on personalized prescription of hormone replacement therapy/menopausal hormone therapy in women at different age period
A significant decrease in estrogen levels due to the onset of menopause is the cause of the development of clinically significant symptoms of climacteric syndrome, which significantly impair the quality of life, and also refers to factors that increase long-term cardiometabolic risks. According to the current Russian clinical recommendations, menopausal hormone therapy (MHT) is considered as the most effective method for the correction of climacteric disorders. An Interdisciplinary Expert Council was convened in the last quarter of 2025 to study the topical issues of managing patients in the peri-and postmenopausal periods and the specifics of prescribing MHT in various clinical situations, the main task of which was to optimize scientifically based algorithms for the management of patients with climacteric/postovariectomy syndromes. Based on the results of work by national and international specialists representing various fields of medicine, a consensus document was approved regulating the principles for prescribing HRT/MHT to women with concomitant somatic pathology.
- 3 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7) , S1-42
Results of the meeting of the Interdisciplinary Expert Council on an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders
The reduction in sex hormone levels during the menopausal period substantially impacts patients’ quality of life and serves as a significant risk factor for psycho-emotional disorders. Current clinical guidelines from both Russian and international sources recognize menopausal hormone therapy (MHT) as the primary method for addressing menopausal disorders. However, selecting dosage forms tailored to the patient’s comorbidities and overall health status is essential. In 2026, the Russian Association of Obstetricians and Gynecologists, the Interdisciplinary Association of Specialists in Healthy Aging and Anti-Aging Medicine, and the Russian Society for the Study of Headache established an interdisciplinary council to implement an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders. The objectives of the expert council included discussing contemporary management strategies for peri- and postmenopausal women and optimizing the application of MHT in complex clinical cases. Additionally, the council aimed to enhance scientific methodologies and devise algorithms for managing patients presenting with menopausal symptoms due to estrogen deficiency, alongside neurological and psycho-emotional disorders. The collaborative efforts of the experts culminated in a consensus document that outlines key principles for the administration of MHT to women with psycho-emotional disorders and somatic comorbidities during the peri- and postmenopausal stages.
- 3 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7) , S1-42
Results of the meeting of the Interdisciplinary Expert Council on an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders
The reduction in sex hormone levels during the menopausal period substantially impacts patients’ quality of life and serves as a significant risk factor for psycho-emotional disorders. Current clinical guidelines from both Russian and international sources recognize menopausal hormone therapy (MHT) as the primary method for addressing menopausal disorders. However, selecting dosage forms tailored to the patient’s comorbidities and overall health status is essential. In 2026, the Russian Association of Obstetricians and Gynecologists, the Interdisciplinary Association of Specialists in Healthy Aging and Anti-Aging Medicine, and the Russian Society for the Study of Headache established an interdisciplinary council to implement an integrated approach to the management of peri- and postmenopausal women with psycho-emotional and neurological disorders. The objectives of the expert council included discussing contemporary management strategies for peri- and postmenopausal women and optimizing the application of MHT in complex clinical cases. Additionally, the council aimed to enhance scientific methodologies and devise algorithms for managing patients presenting with menopausal symptoms due to estrogen deficiency, alongside neurological and psycho-emotional disorders. The collaborative efforts of the experts culminated in a consensus document that outlines key principles for the administration of MHT to women with psycho-emotional disorders and somatic comorbidities during the peri- and postmenopausal stages.
- 3 April 2026
- Published by Taylor & Francis in Research Quarterly for Exercise and Sport
- p. 1-9
Association Between Body Composition and Non-Contact Muscle Injury Risk in Elite Soccer Players: A Cox Proportional Hazards Model Analysis
The study investigated the association between body composition and non-contact muscle injury risk in elite soccer players. Thirty-three elite male outfield players from one Russian Premier League club were monitored across three seasons (2021/22-2023/24). Anthropometry (body-fat %, muscle-mass %, sum of 8 skinfolds, body mass, body mass index) was performed at six standardized time points per season by anthropometrist with The International Society for the Advancement of Kinanthropometry certificate. Non-contact muscle injuries were recorded to International Olympic Committee standards. Time-varying Andersen-Gill Cox models were fit on counting-process intervals with multiple imputation and player-clustered inference; covariates included age, position, seasonal period, exposure minutes, body-fat %, and fat-adjusted muscle residuals. Discrimination was summarized by Harrell's C-index. A total of 54 non-contact muscle injuries were observed in 23 players. Across endpoints, no covariate reached p < 0.05. The body-fat % effect (per 1%-point) was directionally positive for Minimal/Mild injuries (HR = 1.61; 95% CI 0.88-2.93), and closer to null for All (HR = 1.15; 95% CI 0.66-2.01) and Moderate/Severe (HR = 0.62; 95% CI 0.18-2.12). Discrimination was moderate: C-index 0.686 (All), 0.692 (Minimal/Mild), 0.789 (Moderate/Severe). In this cohort of elite soccer players, a higher body fat percentage demonstrated an associational signal with the hazard of minimal and mild muscle injuries, whereas no association was observed for moderate or severe events. Given the observational study design and the potential for residual confounding, these findings should be interpreted as associative rather than causal.
- 3 April 2026
- Published by Taylor & Francis in Research Quarterly for Exercise and Sport
- p. 1-9
Association Between Body Composition and Non-Contact Muscle Injury Risk in Elite Soccer Players: A Cox Proportional Hazards Model Analysis
The study investigated the association between body composition and non-contact muscle injury risk in elite soccer players. Thirty-three elite male outfield players from one Russian Premier League club were monitored across three seasons (2021/22-2023/24). Anthropometry (body-fat %, muscle-mass %, sum of 8 skinfolds, body mass, body mass index) was performed at six standardized time points per season by anthropometrist with The International Society for the Advancement of Kinanthropometry certificate. Non-contact muscle injuries were recorded to International Olympic Committee standards. Time-varying Andersen-Gill Cox models were fit on counting-process intervals with multiple imputation and player-clustered inference; covariates included age, position, seasonal period, exposure minutes, body-fat %, and fat-adjusted muscle residuals. Discrimination was summarized by Harrell's C-index. A total of 54 non-contact muscle injuries were observed in 23 players. Across endpoints, no covariate reached p < 0.05. The body-fat % effect (per 1%-point) was directionally positive for Minimal/Mild injuries (HR = 1.61; 95% CI 0.88-2.93), and closer to null for All (HR = 1.15; 95% CI 0.66-2.01) and Moderate/Severe (HR = 0.62; 95% CI 0.18-2.12). Discrimination was moderate: C-index 0.686 (All), 0.692 (Minimal/Mild), 0.789 (Moderate/Severe). In this cohort of elite soccer players, a higher body fat percentage demonstrated an associational signal with the hazard of minimal and mild muscle injuries, whereas no association was observed for moderate or severe events. Given the observational study design and the potential for residual confounding, these findings should be interpreted as associative rather than causal.
- Open Access
- 7 July 2025
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (7) , 260
Divergent Cardiac Adaptations in Endurance Sport: Atrial Fibrillation Markers in Marathon Versus Ultramarathon Athletes
Endurance training induces significant cardiac remodeling, with evidence suggesting that prolonged high-intensity exercise may increase the risk of atrial fibrillation (AF). However, physiological responses differ by event type. This review compares AF-related markers in marathon and ultramarathon runners, focusing on structural adaptations, inflammatory and endothelial biomarkers, and the incidence of arrhythmias. A systematic analysis of 29 studies revealed consistent left atrial (LA) enlargement in marathon runners linked to elevated AF risk and fibrosis markers such as Galectin-3 and PIIINP. In contrast, ultramarathon runners exhibited right atrial (RA) dilation and increased systemic inflammation, as indicated by elevated high-sensitivity C-reactive protein (hs-CRP) and soluble E-selectin levels. AF incidence in marathoners ranged from 0.43 per 100 person-years to 4.4%, while direct AF incidence data remain unavailable for ultramarathon populations, highlighting a critical evidence gap. These findings suggest distinct remodeling patterns and pathophysiological profiles between endurance disciplines, with implications for athlete screening and cardiovascular risk stratification.
- 7 July 2025
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 12 (7) , 260
Open AccessDivergent Cardiac Adaptations in Endurance Sport: Atrial Fibrillation Markers in Marathon Versus Ultramarathon Athletes
Endurance training induces significant cardiac remodeling, with evidence suggesting that prolonged high-intensity exercise may increase the risk of atrial fibrillation (AF). However, physiological responses differ by event type. This review compares AF-related markers in marathon and ultramarathon runners, focusing on structural adaptations, inflammatory and endothelial biomarkers, and the incidence of arrhythmias. A systematic analysis of 29 studies revealed consistent left atrial (LA) enlargement in marathon runners linked to elevated AF risk and fibrosis markers such as Galectin-3 and PIIINP. In contrast, ultramarathon runners exhibited right atrial (RA) dilation and increased systemic inflammation, as indicated by elevated high-sensitivity C-reactive protein (hs-CRP) and soluble E-selectin levels. AF incidence in marathoners ranged from 0.43 per 100 person-years to 4.4%, while direct AF incidence data remain unavailable for ultramarathon populations, highlighting a critical evidence gap. These findings suggest distinct remodeling patterns and pathophysiological profiles between endurance disciplines, with implications for athlete screening and cardiovascular risk stratification.
- Open Access
Caffeine Effects on Physical Performance and Sport-Specific Skills in Elite Youth Soccer Players: A Randomised Trial Using the Balanced Placebo Design
The aim of the study was to examine the safety and effects of relatively high caffeine doses on physical performance and sport-specific skills of young elite soccer players. Fifty-four soccer players from an elite Russian soccer academy participated in the blinded randomised placebo-controlled study with a double-blinded and balanced design. Participants were divided into four groups: group 1 CAF/CAF; group 2 CAF/PLA group 3 PLA/PLA and group 4 PLA/CAF. All participants were administered 400 mg of caffeine or the placebo. The data demonstrated that a single 400 mg caffeine administration 60 min before exercise had a positive effect on repeated sprint ability (RSA) test parameters such as fatigue index (for both groups p < 0.001) and percentage decrement score (for both groups p < 0.001). In group 4, statistically significant improvements were also found when performing the fourth and sixth sprint during the RSA test (p = 0.039 and p = 0.005, respectively). Group 1 also showed a statistically significant improvement in dribbling speed performance (p = 0.048). It was demonstrated that the number of adverse events in all four groups was not different (p = 0.56). A single administration of 400 mg of caffeine 60 min prior to maximal intensity physical activity can be considered reasonable and safe for young elite soccer players.
Open AccessCaffeine Effects on Physical Performance and Sport-Specific Skills in Elite Youth Soccer Players: A Randomised Trial Using the Balanced Placebo Design
The aim of the study was to examine the safety and effects of relatively high caffeine doses on physical performance and sport-specific skills of young elite soccer players. Fifty-four soccer players from an elite Russian soccer academy participated in the blinded randomised placebo-controlled study with a double-blinded and balanced design. Participants were divided into four groups: group 1 CAF/CAF; group 2 CAF/PLA group 3 PLA/PLA and group 4 PLA/CAF. All participants were administered 400 mg of caffeine or the placebo. The data demonstrated that a single 400 mg caffeine administration 60 min before exercise had a positive effect on repeated sprint ability (RSA) test parameters such as fatigue index (for both groups p < 0.001) and percentage decrement score (for both groups p < 0.001). In group 4, statistically significant improvements were also found when performing the fourth and sixth sprint during the RSA test (p = 0.039 and p = 0.005, respectively). Group 1 also showed a statistically significant improvement in dribbling speed performance (p = 0.048). It was demonstrated that the number of adverse events in all four groups was not different (p = 0.56). A single administration of 400 mg of caffeine 60 min prior to maximal intensity physical activity can be considered reasonable and safe for young elite soccer players.
- 24 December 2024
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 38 (1) , e70002
The Influence of Caffeine on Tolerance to Sport‐Specific High‐Intensity Exercise in Young Elite Soccer Players
Background: Modern elite football places extremely high demands on the athlete's body, so it is of practical interest to study the effect of various dietary supplements on load tolerance and postexercise recovery. Furthermore, there is a lack of research on the effects of caffeine on key measures of load tolerance in football such as delayed‐onset muscle soreness (DOMS), rate of perceived exertion (RPE) and heart rate (HR) at different time points after the exercise.Methods: 54 young players aged 15–17 years from a leading Russian football academy took part in a randomised trial using the balanced placebo design. They were divided into 4 groups: 1 – told caffeine/given caffeine, 2 – told caffeine/given placebo, 3 – told placebo/given placebo and 4 – told placebo/given caffeine. All participants consumed two capsules 60 min before testing, each containing 200 mg of caffeine or placebo. Sprinting, counter‐movement jump, change of direction run, dribbling, T‐test and the repeated sprint ability test were used to create conditions for high‐intensity sports‐specific load. A visual analogue scale was used to assess the severity of muscle soreness. RPE was assessed using the Borg Rating of Perceived Exertion scale. HR immediately postexercise (HRpe), HR after 2 min of passive rest (HRrest) and recovery HR (HRrec = HRpe − HRrest) were obtained.Results: The data demonstrated that a single caffeine intake of 400 mg had no statistically significant effect on RPE (p = 0.948), HRpe (p = 0.698) or HRrec (p = 0.920) across the groups. Additionally, the severity of DOMS 24 h postexercise did not differ significantly between the groups (p = 0.077).Conclusion: Acute caffeine ingestion does not affect the subjective and objective indicators of training load in young football players aged 15–17 years with low levels of anxiety and low levels of daily caffeine intake.
- 24 December 2024
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 38 (1) , e70002
The Influence of Caffeine on Tolerance to Sport‐Specific High‐Intensity Exercise in Young Elite Soccer Players
Background: Modern elite football places extremely high demands on the athlete's body, so it is of practical interest to study the effect of various dietary supplements on load tolerance and postexercise recovery. Furthermore, there is a lack of research on the effects of caffeine on key measures of load tolerance in football such as delayed‐onset muscle soreness (DOMS), rate of perceived exertion (RPE) and heart rate (HR) at different time points after the exercise.Methods: 54 young players aged 15–17 years from a leading Russian football academy took part in a randomised trial using the balanced placebo design. They were divided into 4 groups: 1 – told caffeine/given caffeine, 2 – told caffeine/given placebo, 3 – told placebo/given placebo and 4 – told placebo/given caffeine. All participants consumed two capsules 60 min before testing, each containing 200 mg of caffeine or placebo. Sprinting, counter‐movement jump, change of direction run, dribbling, T‐test and the repeated sprint ability test were used to create conditions for high‐intensity sports‐specific load. A visual analogue scale was used to assess the severity of muscle soreness. RPE was assessed using the Borg Rating of Perceived Exertion scale. HR immediately postexercise (HRpe), HR after 2 min of passive rest (HRrest) and recovery HR (HRrec = HRpe − HRrest) were obtained.Results: The data demonstrated that a single caffeine intake of 400 mg had no statistically significant effect on RPE (p = 0.948), HRpe (p = 0.698) or HRrec (p = 0.920) across the groups. Additionally, the severity of DOMS 24 h postexercise did not differ significantly between the groups (p = 0.077).Conclusion: Acute caffeine ingestion does not affect the subjective and objective indicators of training load in young football players aged 15–17 years with low levels of anxiety and low levels of daily caffeine intake.
- Open Access
- 23 October 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (11) , 6157
Non-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial
Aim. To assess the safety and efficacy of a single intravenous bolus of non-immunogenic staphylokinase compared with alteplase in patients with massive pulmonary embolism and hemodynamic instability. Non-immunogenic staphylokinase is a modified recombinant staphylokinase with low immunogenicity, high thrombolytic activity and fibrin selectivity.Material and methods. This multicenter, open-label, randomized, comparative clinical trial FORPE in two parallel groups was conducted in 23 clinical centers in Russia. A total of 310 patients aged 18 years and older with hemodynamic instability and computed tomography pulmonary angiography verified massive pulmonary embolism and right ventricular dysfunction were included. The patients were randomly assigned in either non-immunogenic staphylokinase (15 mg) or alteplase (100 mg) group. Both medicines were administered intravenously. An independent biostatistician created a randomization sequence using computer-generated random numbers. Randomization was performed using the envelopes. The study was open-label, and emergency unit staff, investigators, and patients were informed about the assigned drug. The primary efficacy endpoint was 7-day all-cause death after randomization. The non-inferiority margin was set at 10% for the difference in 7-day all-cause mortality after randomization between the compared groups. Non-inferiority was tested using the Welch t-test for the primary efficacy endpoint. Secondary efficacy endpoints were analyzed in both the intention-to-treat and per-protocol populations.Results. Of 348 patients screened between December 25, 2020, and July 31, 2023, 310 (89%) were included in the study. Of the total number, 155 (50%) patients were randomized to the non-immunogenic staphylokinase group and 155 (50%) to the alteplase group. In the non-immunogenic staphylokinase group, the primary efficacy endpoint, 7-day all-cause death, was 2% in the intent-to-treat population and 2% in the per-protocol population, whereas in the alteplase group it was 3% (odds ratio (OR) 0,75, 95% confidence interval (CI) 0,11-4,49; p=1,00) and 3% (OR 0,75, 95% CI 0,11-4,52; p=1,00), respectively. The difference in the primary efficacy endpoint was 0,6% (95% CI -2,8 to -4,0) in the intent-to-treat population and 0,6% (95% CI -2,9 to -4,2) in the per-protocol population. Thus, the lower limit of the 95% CI did not cross the non-inferiority margin (pConclusion. Non-immunogenic staphylokinase is at least as effective as alteplase in the treatment of patients with massive pulmonary embolism with hemodynamic instability and has a higher safety profile. Future observational studies of non-immunogenic staphylokinase are needed to continue assessing its safety and efficacy. Given the high safety and efficacy of non-immunogenic staphylokinase, its use should be studied in patients with moderate-to-high risk pulmonary embolism.
- 23 October 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (11) , 6157
Open AccessNon-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial
Aim. To assess the safety and efficacy of a single intravenous bolus of non-immunogenic staphylokinase compared with alteplase in patients with massive pulmonary embolism and hemodynamic instability. Non-immunogenic staphylokinase is a modified recombinant staphylokinase with low immunogenicity, high thrombolytic activity and fibrin selectivity.Material and methods. This multicenter, open-label, randomized, comparative clinical trial FORPE in two parallel groups was conducted in 23 clinical centers in Russia. A total of 310 patients aged 18 years and older with hemodynamic instability and computed tomography pulmonary angiography verified massive pulmonary embolism and right ventricular dysfunction were included. The patients were randomly assigned in either non-immunogenic staphylokinase (15 mg) or alteplase (100 mg) group. Both medicines were administered intravenously. An independent biostatistician created a randomization sequence using computer-generated random numbers. Randomization was performed using the envelopes. The study was open-label, and emergency unit staff, investigators, and patients were informed about the assigned drug. The primary efficacy endpoint was 7-day all-cause death after randomization. The non-inferiority margin was set at 10% for the difference in 7-day all-cause mortality after randomization between the compared groups. Non-inferiority was tested using the Welch t-test for the primary efficacy endpoint. Secondary efficacy endpoints were analyzed in both the intention-to-treat and per-protocol populations.Results. Of 348 patients screened between December 25, 2020, and July 31, 2023, 310 (89%) were included in the study. Of the total number, 155 (50%) patients were randomized to the non-immunogenic staphylokinase group and 155 (50%) to the alteplase group. In the non-immunogenic staphylokinase group, the primary efficacy endpoint, 7-day all-cause death, was 2% in the intent-to-treat population and 2% in the per-protocol population, whereas in the alteplase group it was 3% (odds ratio (OR) 0,75, 95% confidence interval (CI) 0,11-4,49; p=1,00) and 3% (OR 0,75, 95% CI 0,11-4,52; p=1,00), respectively. The difference in the primary efficacy endpoint was 0,6% (95% CI -2,8 to -4,0) in the intent-to-treat population and 0,6% (95% CI -2,9 to -4,2) in the per-protocol population. Thus, the lower limit of the 95% CI did not cross the non-inferiority margin (pConclusion. Non-immunogenic staphylokinase is at least as effective as alteplase in the treatment of patients with massive pulmonary embolism with hemodynamic instability and has a higher safety profile. Future observational studies of non-immunogenic staphylokinase are needed to continue assessing its safety and efficacy. Given the high safety and efficacy of non-immunogenic staphylokinase, its use should be studied in patients with moderate-to-high risk pulmonary embolism.
- Open Access
- 31 August 2024
- Published by Wolters Kluwer Health in Medical Gas Research
- Vol. 15 (1) , 117-119
Carbon monoxide inhalation as a potential aid to enhance aerobic endurance
- 31 August 2024
- Published by Wolters Kluwer Health in Medical Gas Research
- Vol. 15 (1) , 117-119
Open AccessCarbon monoxide inhalation as a potential aid to enhance aerobic endurance
- 16 February 2024
- Published by Taylor & Francis in Journal of Sports Sciences
- Vol. 42 (4) , 373-380
The effects of anti-doping measures on sports performance in weightlifting
Doping is one of the most pressing and prevalent issues in the sports world. Some athletes employ various doping methods to improve performance results, while the World Anti-Doping Agency (WADA) co...
- 16 February 2024
- Published by Taylor & Francis in Journal of Sports Sciences
- Vol. 42 (4) , 373-380
The effects of anti-doping measures on sports performance in weightlifting
Doping is one of the most pressing and prevalent issues in the sports world. Some athletes employ various doping methods to improve performance results, while the World Anti-Doping Agency (WADA) co...